Development and validation of a classification and scoring system for the diagnosis of oral squamous cell carcinomas through confocal laser endomicroscopy by Nicolai Oetter et al.
Oetter et al. J Transl Med  (2016) 14:159 
DOI 10.1186/s12967-016-0919-4
Development and validation of a classification 
and scoring system for the diagnosis of oral 
squamous cell carcinomas through confocal 
laser endomicroscopy
Oetter et al. 
Journal of 
Translational Medicine
Oetter et al. J Transl Med  (2016) 14:159 
DOI 10.1186/s12967-016-0919-4
RESEARCH
Development and validation of a 
classification and scoring system for the 
diagnosis of oral squamous cell carcinomas 
through confocal laser endomicroscopy
Nicolai Oetter1*, Christian Knipfer1,6, Maximilian Rohde1,6, Cornelius von Wilmowsky1, Andreas Maier2,6, 
Kathrin Brunner3, Werner Adler4, Friedrich‑Wilhelm Neukam1,6, Helmut Neumann5,6† and Florian Stelzle1,6†
Abstract 
Background: Confocal laser endomicroscopy (CLE) is an optical biopsy method allowing in vivo microscopic 
imaging at 1000‑fold magnification. It was the aim to evaluate CLE in the human oral cavity for the differentiation of 
physiological/carcinomatous mucosa and to establish and validate, for the first time, a scoring system to facilitate CLE 
assessment.
Methods: The study consisted of 4 phases: (1) CLE‑imaging (in vivo) was performed after the intravenous injection 
of fluorescein in patients with histologically confirmed carcinomatous oral mucosa; (2) CLE‑experts (n = 3) verified 
the applicability of CLE in the oral cavity for the differentiation between physiological and cancerous tissue compared 
to the gold standard of histopathological assessment; (3) based on specific patterns of tissue changes, CLE‑experts 
(n = 3) developed a classification and scoring system (DOC‑Score) to simplify the diagnosis of oral squamous cell 
carcinomas; (4) validation of the newly developed DOC‑Score by non‑CLE‑experts (n = 3); final statistical evaluation of 
their classification performance (comparison to the results of CLE‑experts and the histopathological analyses).
Results: Experts acquired and edited 45 sequences (260 s) of physiological and 50 sequences (518 s) of carcinoma‑
tous mucosa (total: 95 sequences/778 s). All sequences were evaluated independently by experts and non‑experts 
(based on the newly proposed classification system). Sensitivity (0.953) and specificity (0.889) of the diagnoses by 
experts as well as sensitivity (0.973) and specificity (0.881) of the non‑expert ratings correlated well with the results 
of the present gold standard of tissue histopathology. Experts had a positive predictive value (PPV) of 0.905 and a 
negative predictive value (NPV) of 0.945. Non‑experts reached a PPV of 0.901 and a NPV of 0.967 with the help of the 
DOC‑Score. Inter‑rater reliability (Fleiss` kappa) was 0.73 for experts and 0.814 for non‑experts. The intra‑rater reliability 
(Cronbach’s alpha) of the experts was 0.989 and 0.884 for non‑experts.
Conclusions: CLE is a suitable and valid method for experts to diagnose oral cancer. Using the DOC‑Score system, 
an accurate chair‑side diagnosis of oral cancer is feasible with comparable results to the gold standard of histopathol‑
ogy—even in daily clinical practice for non‑experienced raters.
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Background
According to the GLOBOCAN series for the Interna-
tional Agency for Research on Cancer, there is an inci-
dence of 14.1 million new cases of cancer worldwide 
per year. This number is expected to rise substantially 
over the next years [1]. Ten percent of all cancer cases 
are neoplasms of the head and neck area, of which more 
than 90  % are classified as squamous cell carcinomas 
(HNSCCs) [2, 3]. Main risk factors for Squamous Cell 
Carcinomas (SCC) of the oral cavity are the consump-
tion of tobacco or alcohol [4]. In recent times, HNSCCs 
with a Human Papilloma virus infection, especially HPV 
16, have been increasing [5] and represent about 20–25 % 
of all HNSCC cases [6]. Consequently, not only high-risk 
groups associated with alcohol and tobacco use but also a 
growing group of younger patients with HPV-infections 
are affected by cancer in the oral cavity.
Even though the therapy of HNSCCs has improved 
substantially—regarding the advancement in surgi-
cal methods and the development of specific radio and 
chemotherapy regimens over the last decades—one of 
the most crucial factors in the successful treatment of 
oral cancer still remains the early and accurate diagnosis 
[7–9].
The present gold standard for the diagnosis of oral 
malignant neoplasms starts with a visual gross identi-
fication of SCCs and its precursor lesions, followed by 
an invasive biopsy and a histopathological assessment 
[8]. The initial visual examination of the oral cavity is 
regarded as highly subjective, depends on the examiner’s 
clinical experience and requires specific training [5, 10]. 
The subsequent biopsy and histopathological tissue anal-
ysis are time and resource consuming and can also have 
individual variances in diagnosis [11, 12].
Optical imaging methods have the potential to fill the 
gap in daily clinical practice between the subjective visual 
examination and the invasive biopsy followed by a his-
topathological assessment. Confocal laser endomicros-
copy (CLE) was recently introduced as a novel technique 
allowing in vivo microscopic evaluation of the tissue dur-
ing the ongoing examination in real time by providing 
an optical biopsy [3, 13]. This biomedical method could 
enable an in vivo diagnosis and can be reproduced almost 
indefinitely without iatrogenic damage to the patient and 
the need for additional human resources.
Recently, CLE has moved from a research tool to a 
valuable diagnostic technique in medical disciplines like 
gastroenterology [14–18]. Also preliminary results for a 
CLE diagnosis of oral cancer are promising [3, 13, 19–
26]. Transferring first experimental results of CLE in the 
human oral cavity into a valid and evidence based clinical 
setting is an essential step for this imaging tool on its way 
from bench to bedside [27].
The aim of our study was to depict the applicability of 
CLE examinations for diagnosing oral squamous cell car-
cinomas (OSCCs) in comparison to the gold standard of 
histopathological examination. Furthermore, we devel-
oped and evaluated, for the first time in this specialty and 
localization, an easy-to-use and straightforward scor-
ing system for the identification of OSCCs on the basis 
of morphological and architectural criteria in order to 
enable a valid and reproducible CLE assessment even for 
non-experts in their daily clinical practice.
Methods
Study design and setting
An experimental clinical study was carried out to evalu-
ate the clinical benefit of CLE assessment and further-
more to develop and validate a classification and scoring 
system for the diagnosis of squamous cell carcinoma of 
the oral cavity by using CLE with intravenous (IV) fluo-
rescent dye. Prior to examinations, Institutional Review 
Board (IRB) approval was obtained (ethics committee of 
the University of Erlangen-Nürnberg; reference number: 
243_12 B).
The study consisted of four phases: Phase 1, CLE Imag-
ing. Phase 2, validation of the classification performance 
by experts (n = 3) in differentiating between physiologi-
cal and cancerous tissue with the help of CLE and com-
parison to histopathological analyses. Phase 3, analysis of 
collected visual material and development of a classifica-
tion and scoring system by CLE-experienced specialists. 
Phase 4, validation of the scoring system by non-experts 
in the field of CLE (n  =  3) through assessment of the 
reliability in predicting the histopathological classifica-
tion. Comparison of these results with the outcomes by 
experts and the gold standard of histopathology. Evalua-
tion of the inter- and intra-rater reliability.
Patients
Our study is a survey of all inpatients of the Oral and 
Maxillofacial Surgery Department of the Erlangen Uni-
versity Hospital with histopathologically confirmed oral 
squamous cell carcinoma from 5/2013 to 7/2015. Exclu-
sion criteria were defined as follows: age <18 years; cur-
rent pregnancy/lactation period; allergies to fluorescein; 
renal insufficiency at any stage; beta-blocker medica-
tion. All lesions were histologically verified by the gold 
standard of biopsy and histopathological assessment by 
a pathologist specialized in cancer of the head and neck 
region, not involved in the CLE imaging.
Examiners
Two groups of independent examiners participated in the 
rating of CLE video sequences. The first group consisted 
of three medical experts with prior CLE experience. The 
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second group (dentistry fellows; n  =  3) served as non-
experts with no prior experience in CLE imaging.
CLE—experimental setup and dye used
Video sequences were recorded using a stand-alone 
probe-based CLE system (pCLE: ColoFlex UHD Probe, 
Cellvizio, Mauna Kea Technologies, Paris, France). 
This system offers a video frame rate of 12 frames/s, an 
image size of 576 × 578 pixels and a maximum penetra-
tion depth of 65 µm. The field of view has a diameter of 
240  µm. Since normal tissue background fluorescence 
is not able to generate a sufficient signal-to-noise ratio 
[28], intravenous fluorescent dye was applied (fluores-
cein Alcon® 10  %). An initial dose of 3  mL prior to the 
examination with a maximum dose of 7.5 mL of fluores-
cein (IV) during the measurement procedure was defined 
according to experiences of our workgroup in the gastro-
intestinal tract.
Procedure
Phase 1: CLE imaging
All patients were informed about potential risks and 
signed an informed consent form prior to the study 
according to the IRB approval of the ethics committee of 
Friedrich-Alexander-University of Erlangen-Nürnberg 
(FAU, Approval Number 243_12 B). Examinations were 
performed on conscious patients and were totally inte-
grated into the clinical procedure. To enhance image 
quality, the mouth was rinsed with acetylcysteine solution 
(ACC 100 mg Hexal, effervescent tablets) by the patients 
prior to confocal imaging. After the fluorescent agent 
was injected, the probe was gently applied on the sur-
face mucosa. In total, each patient had four sites imaged 
and every location was recorded as individual video 
sequences. Three reference points were determined for 
CLE imaging of physiological tissue: lower inner labium, 
upper alveolar ridge and palatal region. Last measured 
point was the lesion itself (OSCC). CLE imaging of the 
cancerous tissue was conducted in a standardized man-
ner by focusing on the transition between physiological 
oral mucosa and the lesion with a subsequent adjustment 
on the center of the carcinoma.
Phase 2: validation of the classification performance 
in differentiating between physiological and cancerous tissue 
by CLE examinations
The CLE library was presented to experts (n = 3) inde-
pendently and blinded in a random manner. They used 
their own expertise in CLE imaging to classify each 
sequence as “physiological mucosa” or “oral squamous 
cell carcinoma”. The final ratings were statistically com-
pared to the present gold standard for the diagnosis of 
oral cancer (histopathological examination). One of these 
three examiners evaluated all sequences for a second 
time 4  weeks later in order to calculate the intra-rater 
reliability.
Phase 3: development of a classification and scoring system
CLE experts (n  =  3) examined the footage in order to 
identify potential classification parameters for SCCs of 
the oral cavity. They were encouraged to include parame-
ters that are simple, effective and easily applicable in daily 
clinical practice. The relationship between each defined 
parameter and the histological findings was modeled and 
afterwards these criteria were ranked according to their 
importance in identifying OSCCs. A scoring system was 
established on the basis of these findings in multiple dis-
cussion rounds (DOC-Score; Table 1).
Phase 4: validation of the scoring system by assessing the 
reliability of predicting the histological classification
All video sequences were presented to non-experts 
(n = 3; dentists) independently and blinded in a random 
manner. The inexperienced examiners made a classifica-
tion based on our newly developed scoring sheet (DOC-
Score) after being introduced to the field of CLE imaging 
by a unit of instruction slides. This unit presented our cri-
teria list and explained each scoring parameter by using 
typical sample images of physiological tissue (Fig.  1) as 
well as OSCC images (Figs. 2, 3, 4) and the scoring regi-
men. Also potential interfering factors like artifacts or 
mucus at the tip of the probe were discussed in the slides. 
Each criterion of the questionnaire was individually 
based on the presence or absence of specific parameters. 
The sum of all single values was used to decide on a diag-
nosis of “physiological tissue” or “OSCC”.
The ratings of non-experts were statistically compared 
with the results of the examinations by experts and with 
the histopathological assessment. One of these three 
non-experts assessed all sequences once again 4  weeks 
later in order to calculate the intra-rater reliability, as well 
(similar to phase 2). Inter-rater and intra-rater reliability 
was calculated for each of the two groups (experts and 
non-experts).
Statistics
Statistical analyses were conducted with SPSS version 
22 (IBM, Armonk, NY, USA). We calculated occur-
rence frequency, significance (Chi Square) and correla-
tion (Spearman’s rho) with the histopathological result 
of each component of the evaluation criteria. Sensitivity, 
specificity and negative and positive predictive values of 
diagnosing cancer/non-cancer were evaluated with the 
help of our scoring system (non-experts) or the subjec-
tive impression (experts). Inter- and intra-rater reliability 
were calculated using Fleiss’ kappa and Cronbach’s alpha.
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Results
Phase 1: CLE imaging
A total of 95 sequences were acquired (11 sequences 
of the labium, 20 sequences of the alveolar ridge, 14 
sequences of the palatal region and 50 sequences of 
cancerous tissue). The initial CLE library was reduced 
to representative video sequences (n  =  95) with dura-
tions between 1 and 42 s (total 778 s) in order to remove 
artifacts and blind parts (physiological oral mucosa: 
45 sequences/in total 260  s/median: 4  s per sequence; 
squamous cell carcinoma and carcinoma in  situ: 50 
sequences/in total 518 s/median: 6,5 s per sequence).
Phase 2: validation of the classification performance 
in differentiating between physiological and cancerous 
tissue through CLE examinations
The classification performance of the experts (n  =  3) 
is shown in Table  2 (individual and averaged perfor-
mance). Sensitivity and specificity in identifying OSCC 
as well as the positive predictive and negative predic-
tive value for predicting a histopathological OSCC 
diagnosis were calculated for each expert. The aver-
aged sensitivity of experts in diagnosing OSCCs was 
0.953, whereas specificity yielded a value of 0.889. 
Table 1 DOC-Score (diagnosing oral cancer with the help of CLE)
CLE classification and scoring system of oral squamous cell carcinomas
Evaluation criterion Manifestation Score
1. Tissue architecture
 a) Homogeneity Completely organized 0
Organized + unorganized regions 1
Completely unorganized 2
 b) Intercellular gaps Regular 0
Mutated 1
No longer/non‑existent 2
2. Cell morphology Consistent/regular 0
Inconsistent/dysplastic (different sizes/shapes/grey levels) 1
Completely irregular
 Dark, small cells
 Blurry, cloudy image
 Black spot (cell cluster)
2
3. Fluorescence leakage Regular 0
Amplified (bright background) 1
4. Vessels Regular 0
Irregular




x ≥ 5 points = squamous cell carcinoma (SCC) Max. total: 8 points
Fig. 1 CLE‑image of physiological tissue (type of epithelium: 
attached gingiva; location: alveolar process); homogeneous visual 
appearance through completely organized tissue architecture (0p.) 
and slim, accurate intercellular gaps (0p.); consistent cell morphol‑
ogy in shape and color (0p.); no amplified fluorescein leakage (0p.); 
regular vessels (see arrows) (0p.)
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The weighted Fleiss´ kappa coefficient for multi-rater 
analysis was calculated (Table 3). With a value of 0.73, 
substantial inter-individual agreement in diagnosing 
OSCCs through CLE sequences was shown. Addition-
ally one expert subjectively rated the CLE sequences 
after a delay of 4  weeks. The intra-individual abso-
lute agreement measure (Table 4) was excellent with a 
Cronbach’s alpha of 0.989 and an intraclass-correlation 
coefficient of 0.979 (95  % confidence interval between 
0.969 and 0.986).
Fig. 2 OSCC (location: alveolar process); a CLE‑Image: Unorganized tissue architecture (2p.); intercellular gaps not definable in some spots (2p.); 
irregular cells (shape, color and size) and cell cluster (=black spots; 2p.); slightly intensified fluorescein leakage (1p.); vessels not assessable (0p.);  
b Micrograph (HE staining) of the corresponding specimen
Fig. 3 OSCC (location: anterior floor of the mouth); a CLE‑Image: Unorganized tissue architecture (2p.); non‑existent intercellular gaps (2p.); irregular 
cells like cell clusters (=black spots; see arrows) (2p.); amplified fluorescein leakage (1p.); no visible vessel changes (0p.); b Micrograph (HE staining) of 
the corresponding specimen
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Phase 3: development of a classification and scoring 
system
First, experts (n =  3) identified specific parameters that 
are representational of architectural and morphological 
tissue changes in CLE imaging. The occurrence frequency 
of these parameters in physiological as well as in carcino-
matous CLE images is shown in Table  5. Subsequently, 
these items were tested according to their individual 
classification performance. The significance and correla-
tion coefficients of the bivariate correlation model (score 
item—histo-pathological gold standard) is also shown in 
Table 5. Each of the score sheet items showed a significant 
correlation of p  <  0.001 with coefficients ranging from 
0.557 (fluorescein leakage) to 0.936 (homogeneity). Chi 
Square modeling for each item against histopathological 
diagnosis yielded a highly significant difference between 
the expected values and the observed data in each case 
(p  <  0.001). According to that, a score sheet was devel-
oped considering all important morphometric observa-
tions by experts as well as the statistical coefficient values.
During the evaluation of a CLE sequence, each crite-
rion can be considered and rated separately with a score. 
Three point values (0  =  physiological; 1  =  mildly dys-
plastic; 2 = highly dysplastic) were set for each of the fol-
lowing criteria: homogeneity, intercellular gaps and cell 
morphology. Fluorescein leakage and vessel morphology 
scores are represented by two point values (0 = physio-
logical; 1 = dysplastic). The scores are added up to a total 
sum that has a maximum of eight points. According to 
Fig. 4 OSCC (location: anterior floor of the mouth): a CLE‑Image: Completely unorganized tissue architecture (2p.); non‑existent intercellular gaps 
(2p.); blurry, cloudy image because of indistinct cell borders (2p.); no increased fluorescein leakage (0p.); irregular vessels (coiled; see arrows) (1p.);  
b Micrograph (HE staining) of the corresponding specimen showing similar changes in vessel morphology (see arrows), cellular structure and tissue 
architecture
Table 2 CLE classification performance of  the experts 
(subjective evaluation)
PPV positive predictive value, NPV negative predictive value
Expert Sensitivity % Specificity % PPV % NPV %
1 100 (50/50) 95.6 (43/45) 96.2 (50/52) 100 (43/43)
2 86.0 (43/50) 97.8 (44/45) 97.7 (43/44) 86.3 (44/51)
3 100 (50/50) 73.3 (33/45) 80.6 (50/62) 100 (33/33)
Averaged 95.3 (143/150) 88.9 (120/135) 90.5 (143/158) 94.5 (120/127)
Table 3 Inter-rater reliability
Inter-rater reliability of experts (subjective evaluation) and non-experts (using 
DOC-score for diagnosis) in CLE assessment
Examiner Fleis’ kappa Agreement
Expected Observed
Experts (n = 3) 0.730 0.506 0.867
Non‑experts (n = 3) 0.814 0.507 0.909
Table 4 Intra-rater reliability
Comparison of first and second assessment (video sequences; n = 95) executed 
by one expert (subjective evaluation) and one non-expert (scoring system) with 
a delay of 4 weeks




Expert (n = 1) 0.989 0.979 (0.969–0.986)
Non‑expert (n = 1) 0.884 0.792 (0.703–0.856)
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the experts’ opinion and their theoretic modeling of the 
point values for each of the items and the sum score of 
the sheet, a threshold of five points was identified for 
the differentiation between physiological and pathologi-
cal CLE sequences. A point range under 5 indicates the 
diagnosis of “physiological tissue” (0 to 4 points), whereas 
a score of 5 points or higher implies the presence of an 
OSCC (5 to 8 points). The final score sheet is shown in 
Table 1 (DOC-Score).
Phase 4: validation of the scoring system by assessing the 
reliability of the histological classification prediction
The classification performance of non-experts (n  =  3; 
dentists) is depicted according to the expert ratings 
(Table 6). Sensitivity and specificity in diagnosing OSCCs 
as well as the positive predictive and negative predictive 
value for predicting a histopathological OSCC diagnosis 
were also calculated for each non-expert. The inexperi-
enced evaluators’ averaged sensitivity was 0.973 and the 
specificity was 0.881. The weighted Fleiss´ kappa coef-
ficient for multi-rater analysis is also shown in Table  3. 
Non-experts, using the score sheet, yielded a good agree-
ment value of 0.814 in their diagnostic performance. 
In order to assess the performance of the score sheet in 
contrast with the subjective evaluation by the experts, the 
intra-rater reliability (Table 4) was computed for one inex-
perienced examiner in a second step. The intra-individual 
agreement of the non-expert using the score sheet for the 
analysis of the CLE sequences was very good with a Cron-
bach’s alpha of 0.884 and an intraclass correlation of 0.792 
(95 % confidence interval between 0.703 and 0.856).
Discussion
In this study we have shown that expert differentiation 
between physiological and cancerous tissue in the human 
oral cavity with the help of chair-side CLE examination 
and subsequent assessment is a valid diagnostic tool 
with very good results compared to the histopathological 
evaluation.
Furthermore, we were able to ascertain that non-
experts in the field of CLE were able to make a cor-
rect diagnosis of OSCC by using the newly proposed 
classification and scoring system with a classification 
performance similar to the ratings by experts and the his-
topathological analysis.
The evaluation of CLE sequences is subjective and 
a crucial factor in making a correct assessment that 
requires, up to now, the experience and expertise of spe-
cialists. For that reason, and additionally as the mortality 
of patients critically depends on the tumor stage during 
the initial diagnosis [29], there is a need for a more stand-
ardized CLE evaluation for an early and accurate diagno-
sis of OSCC that is effective and easily applicable even for 
non-experts. To reach the aim of a valid and reproduc-
ible assessment in daily clinical practice, especially for 
examiners that are not extensively trained in the field of 
CLE, it was important to develop a straightforward cri-
teria list and scoring system. To proof the validity of our 
newly developed scoring system (DOC-Score), we statis-
tically analyzed non-expert ratings in the differentiation 
of “physiological” and “cancerous” tissue and compared it 
to the results achieved by experts and the histopathologi-
cal assessment.
To the best of our knowledge, there is not yet a stand-
ardized procedure for the evaluation of OSCC-CLE 
sequences. In our study, five criteria were defined, taking 
Table 5 Classification performance of the chosen parameters for the score sheet (by experts)
Occurrence frequency of anomalies (mildly or highly dysplastic) in physiological mucosa and OSCCs, Chi square test and Spearman’s correlation
Parameters 
(score sheet)







P value P value 
(2 tailed)
Spearman’s rho
Homogeneity 15.6 (7/45) 100 (50/50) <0.001 <0.001 0.936
Intercellular gaps 37.8 (17/45) 100 (50/50) <0.001 <0.001 0.880
Cell morphology 28.9 (13/45) 100 (50/50) <0.001 <0.001 0.949
Fluorescein leakage 22.2 (10/45) 78 (39/50) <0.001 <0.001 0.557
Vessel morphology 17.8 (8/45) 92 (46/50) <0.001 <0.001 0.748
Table 6 CLE classification performance of  the inexperi-
enced examiners (evaluation with  newly developed score 
sheet)
PPV positive predictive value, NPV negative predictive value
Non-expert Sensitivity % Specificity % PPV % NPV %
1 100 (50/50) 86.7 (39/45) 89.3 (50/56) 100 (39/39)
2 98.0 (49/50) 80.0 (36/45) 84.5 (49/58) 97.3 (36/37)
3 94.0 (47/50) 97.8 (44/45) 97.9 (47/48) 93.6 (44/47)
Averaged 97.3 (146/150) 88.1 (119/135) 90.1 (146/162) 96.7 (119/123)
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into account the findings and expertise of our workgroup 
in the field of CLE. Furthermore, they were selected by 
correlating our findings to a number of valuable studies 
on tissue morphology of squamous cell cancer (SCC) in 
CLE imaging [3, 13, 23–26, 30].
Squamous cell tissue of the upper aero-digestive tract 
is known to inherit a specific vessel architecture, con-
sisting of small intrapapillary capillary loops [25, 30]. 
Deinert et al. [30] described changes in this vessel archi-
tecture for early SCCs of the esophagus via CLE imag-
ing. Dilated and elongated intrapapillary capillary loops 
were reported in malignant squamous cell tissue as a 
fundamental parameter for tissue characterization in 
this study. We have found similar results in our study for 
SCCs of the oral cavity and thus included the vessel mor-
phology as one main criteria in our CLE scoring system 
(Fig.  4). Prior studies concerning CLE imaging of SCCs 
focused on specific tissue patterns and cellular compo-
nents that are characteristic for malignancy [25, 31]. Liu 
et  al. [25] identified dark epithelial cells with irregular 
arrangement as distinctive for SCCs of the esophagus. 
These characteristic changes in malignant mucosa are in 
accordance with OSCCs as we have found in the present 
study. As the study on tissue architecture as well as cell 
morphology is a main aspect in CLE-imaging and their 
alterations are found as being typical in SCCs, two eval-
uation criteria—namely “tissue architecture” and “cell 
morphology”—have been included in our scoring system. 
Haxel et al. investigated one patient with a carcinoma of 
the floor of the mouth [13] and noticed, besides irregular 
cell patterns and extended capillaries, a leaking of con-
trast agent in confocal images. Additionally Nathan et al. 
[23] described a disorganized epithelium with fluorescein 
leakage in CLE images in one case of squamous cell carci-
noma of the tongue. Our findings, concerning increased 
fluorescence leakage in SCC, are in accordance to these 
findings. Therefore we integrated the fluorescein leakage 
as a further main criterion into our DOC-Score.
Thus, the following five parameters were defined in our 
DOC-Score sheet: 1. tissue architecture (1.a homogene-
ity, 1.b intercellular gaps), 2. cell morphology, 3. fluores-
cein leakage and 4. vessel morphology. This set of criteria 
was reviewed and adjusted in multiple discussion rounds 
and has been strengthened through statistical methods 
as well as correlation modeling to test the suitability of 
these items. Exemplary, histological images and their cor-
responding CLE images are illustrated in Figs. 2, 3 and 4.
Basically, as more dysplastic manifestations get higher 
scores, a high total sum indicates OSCC when a certain 
threshold is reached (Table  1, DOC-Score). This thresh-
old was adjusted and validated according to expert rat-
ings. For this purpose, video sequences not easily or 
clearly assessable were used by the experts to perform 
some exemplary calculations in order to determine the 
proper threshold.
Our final statistical analysis showed that the clas-
sification performance of inexperienced professionals 
was comparable to the subjective diagnoses by experts 
if the preconditions of (a) an introduction in the field 
of CLE imaging by standardized slide shows and (b) a 
rating based on our newly developed score sheet were 
given. Furthermore, a slightly better inter-rater agree-
ment by laypersons was yielded when applying the score 
sheet. Thus, good standardization and comparability of 
the CLE assessment procedure can be ensured for non-
experts as well. The intra-rater reliability between the 
first and the second assessment of the images was bet-
ter for experts than for non-experts. This suggests that, 
in our opinion, inexperienced evaluators need rein-
forcement of the learned lessons at regular intervals in 
order to maintain the positive learning effect and thus 
maintain a high level of accuracy in their diagnoses. In 
spite of the valuable promising results for non-experts, 
one has to mention that (a) data collection i.e. the han-
dling of the CLE measuring unit and (b) the detection 
and selection of representative sequences is an integral 
part of CLE examinations. Both parts were conducted by 
experts in this study. The performances of the inexperi-
enced examiners in this field of CLE examinations (data 
collection and sequence selection) were not subject of 
the present study.
In general, CLE for the imaging of bio-tissue on a 
microscale has yet to be applied in various medical dis-
ciplines including urology, pulmology, dermatology and 
gastroenterology with good prospects [14, 16, 17, 28]. 
Recent studies showed promising results regarding a 
transfer of this imaging method to the area of the head 
and neck with a sufficient differentiation of pathologi-
cal lesions to physiological tissue in the upper gastroin-
testinal tract like pharynx, larynx and the esophagus [3, 
24–26]. Furthermore, preliminary results regarding CLE 
examinations in the oral cavity showed potentials for 
detecting cancerous lesions even in their early forms. 
However, these studies were mainly performed either 
with an experimental set-up, in ex vivo settings, on ani-
mal models or with fluorescent agents not suitable for a 
routine clinical investigation [3, 13, 19–22, 24–26].
A preliminary CLE study has evaluated the identifica-
tion of non-dysplastic, precancerous and cancerous spots 
of the oral cavity by experts with high sensitivities of 
80–100 %, as well [23]. However, no specific criteria were 
defined in that study prior to diagnosis regarding the 
diagnostic process of these entities. Furthermore, Pogor-
zelski et  al. [3] described morphological criteria in CLE 
imaging of HNSCC regarding the malignant transforma-
tion of mucosal tissues. No statistical evaluation of their 
Page 10 of 11Oetter et al. J Transl Med  (2016) 14:159 
criteria has yet been performed. Both working groups 
used experienced investigators as raters.
Our study has some potential limitations: One of 
them is the number of evaluators (n  =  3) who applied 
our newly developed classification and scoring system 
in order to validate this score. We generated signifi-
cant results but there is a need for further validation of 
the criteria list and scoring system with a greater num-
ber of examiners (non-experts) and a larger video data-
base. Furthermore, comparative pictures of apparently 
physiological tissues were generated in the same patient 
cohort. Consequently, we cannot completely exclude the 
possibility, like in similar studies of other groups [23, 32], 
that these visually identified physiological spots (refer-
ence points) could even be degenerated or dysplastic at 
an earlier stage (no biopsies with histopathological veri-
fication). Measuring points of physiological tissue were 
defined in advance. There is a need to generate pictures 
of other localizations, like the dorsal tongue (footage is 
difficult to generate because of the different surface com-
position [33]) or buccal mucosa. Prospectively, an “opti-
cal landscape” of the entire oral cavity should be created, 
to have the option for comparison in every part of the 
mouth (for example keratinized versus non-keratinized 
tissue). Another limitation caused by the technical con-
ditions of pCLE is the limited penetration depth that 
only enables imaging of superficial mucosa. Submucosal 
lesion cannot be detected and monitored over time.
In this study we included patients with histopathologi-
cal confirmed SCCs and differentiated between physi-
ological and malign (OSCC) tissue with the help of the 
DOC-Score. In our opinion—at the current state of 
research—this is an essential step that should be built on 
further. Consequently, there is a need of research work 
with an enlarged patient size including other entities like 
precursor lesions of cancer (leukoplakia etc.) or mucosal 
inflammatory reactions to enable a separation of these 
entities towards physiological or cancerous mucosa in 
future.
Conclusions
In summary, CLE enables a relatively unlimited repro-
ducibly and non-invasive “optical biopsy” for the real-
time diagnosis of pathologies. In the area of oral and 
maxillofacial surgery, it has the potential to reduce the 
diagnostic time, the morbidity in the sense of an early 
detection as a screening method and furthermore to 
identify the exact location and superficial spreading of 
tumorous mucosa. In order to accomplish these goals, a 
transfer of the experimental knowledge of CLE imaging 
in oral and maxillofacial surgery to daily clinical practice 
through standardized diagnostic procedures is needed. 
In this study—for the first time in this specialty—with 
the help of pCLE, an effective and valuable scoring sys-
tem was developed for the diagnosis of OSCCs. This ena-
bles a reliable classification of physiological mucosa and 
cancerous lesions even for non-CLE-experts in their daily 
clinical practice. Multicenter studies are now highly war-
ranted to prove our initial findings.
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